Curated Content | Thought Leadership | Technology News

Hershey Appoints Its First Ever Chief Technology Officer

This will be Bhatia’s first CTO role, further sweetening the deal for both parties.
Joshua Koszalkowski
Contributing Writer

The Hershey Company (HSY), an industry-leading snacks company, appointed Deepak Bhatia as its first Chief Technology Officer (CTO), effective October 23. As CTO, Bhatia will spearhead Hershey’s global technology strategy. In doing so, he will be responsible for building and dispatching the digital capabilities necessary to meet the changing needs of the company’s consumers, retail partners and employees.

Bhatia joins the snack giant from Amazon, where he’s spent the last 12 years in the supply chain optimization side of the business. In his current role as Vice President, Supply Chain Optimization Technologies, he leads the group that manages software engineering, product management and science for Amazon’s core supply chain management. Bhatia directs his team to create algorithms to improve the company’s inventory and operational efficiency on a global scale. Prior to joining Amazon, he spent 11 years with Applied Materials, a leader in materials engineering solutions used to produce new chips and advanced displays.

“I am honored and humbled to be joining Hershey, a company with an incredible legacy and culture,” said Bhatia. “We are experiencing unprecedented technological innovation, and I am thrilled to spearhead the development and execution of a technology-driven transformation that will meet and exceed the evolving needs of our consumers and customers. I look forward to shaping a future of innovation and excellence.”


CIOs on the Move is brought to you by CIO Partners®. When hiring your next technology executive, experience matters. Trust CIO Partners, the #1 executive search firm for technology leadership talent.


×
You have free article(s) left this month courtesy of CIO Partners.

Enter your username and password to access premium features.

Don’t have an account? Join the community.

Would You Like To Save Articles?

Enter your username and password to access premium features.

Don’t have an account? Join the community.

Register for Unlimited Access

Already a member?

Digital Monthly

$12.00/ month

Billed Monthly

Digital Annual

$10.00/ month

Billed Annually

Plastic robot arm pointing at DNA. Artificial intelligence genet
Insilico Medicine, a biotech startup, has created the first drug entirely developed by artificial intelligence (AI) that has entered clinical trials with human patients. The...

Would You Like To Save Books?

Enter your username and password to access premium features.

Don’t have an account? Join the community.

Log In To Access Premium Features

Sign Up For A Free Account

Please enable JavaScript in your browser to complete this form.
Name